Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Suraksha Diagnostic Ltd. ( (IN:SURAKSHA) ) is now available.
Suraksha Diagnostic Limited has notified the exchanges that it is closing its trading window for designated persons and their immediate relatives from 1 April 2026 until 48 hours after the release of its audited standalone and consolidated financial results for the quarter and financial year ended 31 March 2026. The move, taken under SEBI’s insider trading regulations and the company’s internal code of conduct, signals that year-end financials are being finalized and underscores its adherence to governance norms, with the board meeting date for approving results to be announced later and details made available on the company’s website.
More about Suraksha Diagnostic Ltd.
Suraksha Diagnostic Limited operates in India’s healthcare diagnostics sector, providing pathology and radiology testing services through its network in West Bengal and other regions. The company focuses on clinical diagnostics for retail patients, hospitals, and doctors, positioning itself as a key regional player in diagnostic services with a growing presence in organized healthcare testing.
Average Trading Volume: 1,219
Technical Sentiment Signal: Strong Sell
Current Market Cap: 13.17B INR
For detailed information about SURAKSHA stock, go to TipRanks’ Stock Analysis page.